The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according to new data released in The Lancet on World Diabetes Day.  The data was part of an analysis conducted by the NCD Risk Factor Collaboration,

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of weekly injections. The results suggest that tirzepatide - the active ingredient in Lilly's diabetes drug Mounjaro and weight-loss treatment Zepbound - could prevent one new case of diabetes for every nine patients treated.

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss. Whether you have type 2 diabetes or obesity, you may have heard about medications like Ozempic® that can help manage blood sugar levels and weight.

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight management but for many people, there are still questions around side effects, accessibility and results.

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

Dr. Darien Sutton and Dr. Stephanie Widmer discuss new studies, which found GLP-1 weight loss drugs beneficial in fighting Type 2 diabetes and certain addiction disorders.

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.